On this section of the website, you can find a list of the most recent votes from
the House of Representatives. If you have questions about a vote, please do not
hesitate to contact us.
Vote Explanations
What is the difference between Yay/Nay votes and Aye/No votes?
The distinction relates to whether Members are meeting as the full House of Representatives
or as the Committee of
the Whole. To learn more,
click here.
Providing for consideration of the bill (H.R. 4346) making appropriations for Legislative Branch for the fiscal year ending September 30, 2022, and for other purposes; providing for consideration of the bill (H.R. 4373) making appropriations for the Department of State, foreign operations, and related programs for the fiscal year ending September 30, 2022, and for other purposes; and providing for consideration of the bill (H.R. 4505) making appropriations for the Departments of Commerce and Justice, Science, and Related Agencies for the fiscal year ending September 30, 2022, and for other purposes.
Providing for consideration of the bill (H.R. 4346) making appropriations for Legislative Branch for the fiscal year ending September 30, 2022, and for other purposes; providing for consideration of the bill (H.R. 4373) making appropriations for the Department of State, foreign operations, and related programs for the fiscal year ending September 30, 2022, and for other purposes; and providing for consideration of the bill (H.R. 4505) making appropriations for the Departments of Commerce and Justice, Science, and Related Agencies for the fiscal year ending September 30, 2022, and for other purposes.
Providing for consideration of the bill (H.R. 4346) making appropriations for Legislative Branch for the fiscal year ending September 30, 2022, and for other purposes; providing for consideration of the bill (H.R. 4373) making appropriations for the Department of State, foreign operations, and related programs for the fiscal year ending September 30, 2022, and for other purposes; and providing for consideration of the bill (H.R. 4505) making appropriations for the Departments of Commerce and Justice, Science, and Related Agencies for the fiscal year ending September 30, 2022, and for other purposes.
Amendment sought to allow United States researchers to study and examine the potential impacts of several schedule I drugs, such as MDMA, psilocybin, and or ibogaine, that have been shown to be effective in treating critical diseases.